Bright light therapy in the treatment of childhood and adolescence depression, antepartum depression, and eating disorders by unknown
BIOLOGICAL CHILD AND ADOLESCENT PSYCHIATRY - REVIEW ARTICLE
Bright light therapy in the treatment of childhood and adolescence
depression, antepartum depression, and eating disorders
Krzysztof Krysta • Marek Krzystanek •
Małgorzata Janas-Kozik • Irena Krupka-Matuszczyk
Received: 28 January 2012 / Accepted: 30 June 2012 / Published online: 19 July 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Circadian rhythm disorders represent an
important component underlying the pathology of depres-
sion. One of the subtypes of depression, in which these
disorders may play a crucial role, is the seasonal affective
disorder (SAD). The bright light therapy (BLT) has been
reported as a novel, promising treatment method for SAD
since 1984, and most of the data revealing its efficacy has
been referred to adult patients, without comorbid disorders.
However, in the recent years, more and more reports have
been presented, which confirm the usefulness of BLT in
some specific subpopulations of patients, including chil-
dren, adolescents and pregnant women. The present review
summarizes the applications of BLT in antepartum
depression, childhood and adolescence depression as well
as in patients suffering from eating disorders. Although the
body of evidence is still too small to recommend the use of
BLT as the first line of treatment for the depression or
eating disorders in these patient subpopulations; it appears
that BLT may be a useful alternative or adjunctive therapy
for these diseases. However, the specific clinical applica-
tions of BLT in these areas need further investigation.
Keywords Bright light therapy (BLT)  Antepartum
depression  Depression of childhood and adolescence 
Eating disorders
Introduction
A possible connection between the psychopathology of
depressive disorders and circadian rhythms has been pos-
tulated for many years; however, the underlying biological
mechanisms still remain unexplained. There are some data
suggesting that the effect of antidepressive medications is
at least partially due to their action on the circadian
rhythms (McClung 2007). Exploring of the neurobiological
mechanisms has contributed to the discovery of so-called
clock genes, which are present in many cells of the central
nervous system, and which are responsible for the circadian
rhythm abnormalities, leading to disrupted behavioral
states (Turek 2007). These biological connections may
explain how close are the relations between sleep disorders
and depressive symptoms. According to Harvey (2011),
sleep disturbances are important, but still under-recognized
mechanisms, related to the etiology and clinical course of
mood disorders. In particular, abnormal sleep patterns may
be risk factors for the relapse of depressive episodes as well
as for the deterioration of cognitive and emotional regu-
lation, and hormonal or metabolic disorders.
According to Antonijevic (2008), there may be different
subtypes of depression, due to some alterations in func-
tioning of the hypothalamic–pituitary–adrenal (HPA) axis,
and different patterns of sleep architecture. This kind of
distinction may serve as a future marker, potentially
helpful in the selection of individually targeted treatment
strategies. One of the first subtypes of depression, in which
the positive effects of bright light therapy (BLT) were
observed, was the seasonal affective disorder (SAD). Ro-
senthal et al. (1984) reported the first attempt of using BLT
in a group of 29 patients, who were diagnosed with the
bipolar disorder. Since that time, a number of studies
analyzing the efficacy of BLT have been published. The
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mechanism of BLT is complex and different explanations
have been proposed, including the circadian rhythm
hypothesis, based on the sleep phase shift. This might mean
that the individuals suffering from SAD during the winter
might have the sleep phase delayed or advanced, in relation
to their sleep/wake cycle (Lewy et al. 2007). It is assumed
that BLT applied in the morning reduces the secretion of
melatonin in phase-shift delay. Depending on the individ-
ual circadian rhythm changes, the morning or evening BLT
application could be indicated as adjunctive chronobio-
logical treatment methods for SAD.
Biological mechanisms of the BLT action
One of the most important anatomical structures, respon-
sible for mood control is the suprachiasmatic nucleus
(SCN), which is considered to be the circadian pacemaker
of many different physiological and behavioral processes
(Arushanian and Popov 2011). The neuronal activity of
SCN is regulated by two G-protein coupled melatonin
receptors, MT1 and MT2, and by melatonin secretion from
the pineal gland. SCN receives neuronal impulses from the
retina via the retinohypothalamic tract (Dubocovich 2007).
Therefore, the level of melatonin secretion depends on the
exposure to light during the day time, and also, on the
season of the year. The exact way of the SCN regulation
still remains hypothetical. One possibility is that the in-
dolamines (melatonin and its precursor serotonin) have an
ability to transduce light signals into the SCN. Another
explanation is that the serotonin may play some role in the
modulation of SCN networks, and in melatonin production
by the pineal gland that influences biological rhythms.
Moreover, it has been hypothesized that the light exerts
neurotrophic influence on neurons, and thus, a prolonged
light deprivation can cause functional impairments of the
noradrenergic-locus coeruleus system. In their experimen-
tal work, Gonzalez and Aston-Jones (2008) showed that the
permanent light deprivation in rats increased apoptosis in
the locus coeruleus; however, this effect can be reversed by
some antidepressant drugs.
Also, there are some studies suggesting that the mech-
anism of antidepressant effect of BLT is connected with the
functional augmentation of serotonergic and noradrenergic
network systems. As an illustration, a tryptophan-free diet,
and an administration of the hydroxylase inhibitor, alpha-
methyl-paratyrosine produce a robust increase of the
depressive symptoms in patients diagnosed with SAD,
while BLT administration remits these symptoms (Neu-
meister et al. 1998). It can be considered that the action of
BLT is related to the augmentation of serotoninergic and
noradrenergic transmission systems. In a study by Stastny
et al. (2003), the serotoninergic and noradrenergic
depletions in patients with SAD, who were in remission
after receiving BLT, produced a transient reduction in
plasma interleukine 4 levels. This may suggest that the
BLT may influence the immune system regulation, which
is often distorted in depression.
In addition, the alterations in neurohormones such as
ghrelin and leptin may be involved in the pathophysiology
of SAD. This can result in hyperphagia, with cravings for
carbohydrates, and subsequently, can contribute to a
moderate weight gain that frequently accompanies
depressive and obsessive–compulsive disorders, which
might favorably respond to BLT (Cizza et al. 2005; Gar-
aulet et al. 2011).
According to the clinical observations by Praschak-
Rieder and Willeit (2003), the morning BLT may be
superior to the evening one, since it reduces the secretion
of melatonin in phase-shift delay. The duration and fre-
quency of BLT exposure are still controversial (Kron-
feld-Schor and Einat 2012). For instance, Reeves et al.
(2012) reported that a significant improvement in the
depression scores can be found even after a single BLT
session.
Development of indications for BLT
Golden et al. (2005) published a meta-analysis of studies
reporting positive effects of BLT in affective disorders.
The authors emphasized the existing differences in the
methodology of the analyzed publications, including lack
of rigorous study design. Nevertheless, in a majority of
randomized, controlled studies, the beneficial effects of
BLT in SAD and other depressive disorders were evident
and comparable with the ones using antidepressants. This
meta-analysis included only the studies, which enrolled
adult patients (aged 18–65 years), and excluded the ones,
which investigated children, adolescents and elderly
patients. An interesting review was done by Pail et al.
(2011), in which the authors paid a special attention to
numerous obstacles that the researchers may encounter in
designing their study protocols. The authors indicate that
BLT is an efficacious, but probably underestimated treat-
ment method for affective disorders, with good tolerability
and acceptance.
Recently, some reports related to the BLT efficacy in
depressive disorders among elderly patients have been
found in the literature (Young 2011). Furthermore, the
latest reports on the BLT clinical applications have
revealed some new, potential indications, including ante-
partum depression, depression of childhood and adoles-
cence. In these patient populations, a good tolerance of side
effects is very important, and thus, novel, adjunctive forms
of treatment are needed.
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Antepartum depression
The prevalence of antepartum depression differs according
to the available sources, and can be estimated within the
range 5–15 % (Chatillon and Even 2010; Oren et al. 2002).
According to Bader et al. (2010), about 11 % of the
pregnant women suffer from a major depressive disorder,
which requires treatment. Under these circumstances, BLT
can be one of the proposed therapeutic options, adjunctive
to psychotherapy, antidepressants or electroconvulsive
therapy (ECT). However, the literature reporting the results
of non-pharmacological clinical trials in this area is still
limited (Terman 2007; Golden et al. 2005). In their review
of treatment methods used for the depression in pregnancy,
Frisch and Riecher-Ro¨ssler (2010) and Ryan et al. (2005)
proposed BLT as an alternative to antidepressants and
psychotherapy. Similarly, Chatillon and Even (2010)
reviewed the contemporary studies on antepartum depres-
sion and reported that the most widely used were tricyclic
antidepressants and serotonin selective reuptake inhibitors
(SSRIs), while the ECT was applied only in the most
severe cases. They also documented that BLT seems to be
effective; however, the studies are scarce and often
inconclusive. In a study by Oren et al. (2002) in the group
of 16 pregnant women, BLT was found to be effective in
improving the Hamilton Depression Rating Scale (HDRS)
scores by 49 % after 3 weeks of treatment. Moreover,
Epperson et al. (2004) reported successful treatment results
of 10 pregnant women (enrolled in a randomized clinical
trial) diagnosed with a major depressive disorder. In his
review, Terman (2007) attempted to summarize the avail-
able research data concerning the application of BLT in
pregnant women. However, he noted that in the past, this
group of patients had been routinely excluded from the
clinical trials, due to caution for the fetus. In one of the
recent studies [a 5-year randomized, controlled clinical
study by Wirz-Justice et al. (2011)], 27 pregnant women
with non-seasonal major depressive disorder were treated
with 7,000 lux bright light in the morning for 1 h/day,
during a 5-week period. The authors reported that this
5-week BLT improved the depression in pregnancy, com-
pared to placebo.
The treatment of depression during pregnancy is a
demanding clinical challenge, which requires a consider-
ation of the treatment risk, related to the fetus. Based on the
above observations, BLT has been proposed as an alter-
native to antidepressant medication and was included into
the recommendations of the Committee on Chronothera-
peutics, delegated by the International Society for Affec-
tive Disorders (ISAD), for the use in patients who refuse,
resist or cannot tolerate medication, or for whom medica-
tions may be contraindicated, as in a case of the antepartum
depression (Wirz-Justice et al. 2005). It is worth
emphasizing that the successful treatment of depression in
pregnancy is related not only to clinical symptoms but also
to some neurohormonal and endocrine patterns. Parry et al.
(2006) measured the plasma levels of melatonin in preg-
nant women with depressive disorders and found that there
was a lower mean melatonin amplitude, with lower mean
evening cortisol levels, as compared to those levels in
healthy controls. According to Parry and Newton (2001),
the clinical improvement of antepartum depressive symp-
toms can be associated with the phase advances, of the
melatonin rhythm. The above reports were also supported
by our own clinical observation, describing the effects of
depression treatment in three pregnant women (Krzystanek
and Krupka-Matuszczyk 2006). These women were out-
patients in 6, 7 and 8th-month of pregnancy, diagnosed
with moderate depression, according to the ICD-10 criteria.
Their treatment consisted of a morning exposure to
5,000 lux BLT for 1 h, from Monday to Friday. Antide-
pressant effects were assessed after the 2nd and the 4th
week of BLT. The mean improvement of depressive
symptoms was 33 and 55 % after 2 and 4 weeks of BLT,
respectively. No side effects were observed in any of the
patients. We have reported that the morning BLT is an
effective and very well tolerated mode of treatment in
pregnant women, suffering from non-seasonal depression.
However, the exact technique and duration of BLT initia-
tion and maintenance treatment require further studies.
Antepartum depression is common in clinical practice,
potentially endangering both the mother and her fetus. The
adverse outcomes of antepartum depression include deliv-
ery complications and postpartum depression. In addition,
there is an increased risk for preterm birth, low birth
weight, and sudden death of the child (Chatillon and Even
2010). Therefore, the treatment requires an immediate and
serious consideration and should not be postponed until the
depression aggravates to more advanced stage.
Depression of childhood and adolescence
The literature reports some important differences between
the treatment of depression in adults, and in children and
adolescents. For example, some antidepressants effective
in adult patients cause no improvement in the young patient
population (Tsapakis et al. 2008). Although, this phenom-
enon has not been fully explained, one of the reasons for it
may be the maturation of serotoninergic and noradrenergic
systems (Bylund and Reed 2007). It is important to find out
whether this type of differences might also be present in
case of the BLT application. Some research trials, con-
ducted in the 80 s, were focused on the efficacy of BLT but
were confined to the adult patients. The initial observations
of the BLT application in children and adolescents were
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published in the 90 s by Sonis et al. (1987). Mghir and
Vincent (1991) reported a case study of a 16-year-old girl
with a 3-year history of SAD. After the phototherapy, a
remission of her symptoms was observed. A few years
later, the first analysis, referring to a larger group of
patients, revealed the differences between SAD in adoles-
cents and in adults (Glod et al. 1997), suggesting that the
disregulated circadian rhythm patterns in children are
comparable to those reported in non-seasonally depressed
children; however, they are different from those observed
in adults. This concept was further investigated in a study
by Swedo et al. (1997), in which 28 children (aged
7–17 years) with pediatric SAD were enrolled in a double-
blind, placebo-controlled BLT trial. The total depression
scores were significantly decreased during this treatment,
indicating that BLT might be an effective treatment for
pediatric SAD. However, these findings must be approa-
ched with caution, pending further studies in this area.
Eating disorders
The application of BLT has also been connected with some
comorbidities in the adolescent patients, who may present
not only depressive symptoms but also with other co-
existing disorders. The rational explanation for the BLT
use in eating disorders is its modulatory effect on the
serotoninergic system functioning (Neumeister et al. 1998)
which may be also deregulated in the eating disorders
(Kaye et al. 2005). Symptoms of obsessive compulsive
disorder (OCD) are common in both adults, and children
and adolescents with anorexia nervosa (AN) (Hirani et al.
2010), and might be a part of the OCD-spectrum disorders
(Altman and Shankman 2009). Based on this concept, a
trial aimed at assessing the effects of 6-week BLT on
depressive symptoms was conducted among 24 female
patients with the restrictive type of anorexia nervosa (AN-
R) (Janas-Kozik et al. 2011). In this study, 12 subjects were
randomly assigned to the BLT (10,000 lux, 30 min daily)
intervention. The study patients did not suffer from
depression prior to their AN onset. The depressive symp-
toms, observed in the study group, appeared to be sec-
ondary to the AN course. In addition, the depressive
symptoms reported from this group of patients with AN-R
did not have seasonal characteristics. These findings indi-
cate that the improvement of depressive symptoms is sig-
nificantly greater in the group receiving BLT. Moreover, a
significant difference between the study groups (receiving
BLT vs. control) with regard to the depression intensity
scores after 5 and 6 weeks has been reported. The limita-
tion of this study was its short observation period, and thus,
in the future trials, a longer observation time would be
needed to determine whether BLT may also be effective for
preventing the relapse of depressive symptoms in AN-R
patients. Despite these limitations, the results of this study
suggested that BLT could be an effective non-pharmaco-
logical modality for the treatment of depression, in patients
with AN-R.
This interesting issue of the symptom overlap between
the depression and eating disorders was also observed in
some earlier studies. In attempt of applying BLT in this
type of comorbidity, Lam et al. (1994) described a group of
17 depressed patients with bulimia nervosa (BN), in whom
it was found that BLT improved their symptoms, related
both to the depression and eating disorder. However, the
therapeutic effect of BLT in BN was greater in those
patients, who suffered from a seasonal pattern. In a relevant
case study by Ash et al. (1998), it was documented that the
symptoms of eating disorder and depression had improved
after 1 month of BLT. Furthermore, Daansen and Haff-
mans (2010) studied five women with chronic AN, who
were treated with BLT, and reported that there is a short-
term positive effect of BLT on the anorexia symptoms.
This finding suggests that the series of BLT procedures
could be repeated after 3 months to augment the beneficial
therapeutic effects.
In a double-blind, placebo-controlled study, Braun et al.
(1999) described that BLT reduces binge frequency in 16
bulimic women, treated with 10,000 lux, in comparison
with 18 patients receiving the dim red light (50 lux) ther-
apy. However, there are also some negative results, pub-
lished in the literature, concerning the improvement of BN
symptoms after the BLT application (Blouin et al. 1996). In
summary, the results of studies investigating the effects of
BLT on AN and BN symptoms still remain controversial,
and thus, more long-term studies are necessary to elucidate
this alternative therapeutic possibility.
Conclusion
The BLT has been used as a treatment method for SAD.
However, the most convincing evidence of its efficacy has
been based on the studies referring to adult patients without
comorbidities. Recently, the usefulness of BLT in some
other psychiatric conditions has been illustrated in new
therapeutic recommendations, including antepartum
depression and depression of childhood and adolescence.
Antepartum depression is a specific type of psychiatric
disorder, in which a particular attention must be paid to the
side effects of the treatment, especially for the fetus. Cur-
rently, BLT is a method considered to have minimal side
effects for the mother and no known risk for the unborn
child (Wirz-Justice et al. 2011).
In pregnant females, the rational use of pharmacother-
apy or ECT was often limited due to possible adverse
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effects. Psychotherapy remained the safest method,
although not always effective. Although more research is
needed, the available results are fairly convincing that the
BLT, as one of the treatment methods for antepartum and
postpartum depression, presents a safe and effective alter-
native to pharmacotherapy (Golden et al. 2005).
As noted before, the early literature on the application of
BLT in depression was limited to the adult population.
After distinguishing certain differences between SAD in
adults and in adolescents, the studies on BLT application
confirmed its positive effects among children and adoles-
cents (Sonis et al. 1987; Glod et al. 1997; Swedo et al.
1997).
In summary, the use of BLT in the depression of
childhood and adolescence, and in the antepartum depres-
sion remains a promising alternative form of biological
treatment, which is both effective and well tolerated.
However, one should be aware of the fact that the body of
evidence is still too small to create a strong recommen-
dation for the use of BLT as the first line of treatment for
depressive (childhood and adolescence and antepartum
depression) or eating disorders (AN and BN), and future
long-term studies on larger populations are necessary in
this field. Overall, the existing research results are prom-
ising and should encourage investigators in their search in
this area.
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